Technology & Information Law Blog by Charles Gideon Korrell

Category: Patent Law

  • Federal Circuit Reverses JMOL in Steuben Foods Patent Case: Key Takeaways for IP Law

    In Steuben Foods, Inc. v. Shibuya Hoppmann Corporation, the Federal Circuit issued a major decision addressing key intellectual property issues related to patent infringement, claim construction, and the reverse doctrine of equivalents (RDOE). The case centered on aseptic food packaging technology, with the court analyzing whether Shibuya’s P7 aseptic bottling line infringed Steuben’s patents.

    This ruling highlights several crucial aspects of IP law, including the viability of RDOE as a defense, the interpretation of means-plus-function claims, and the application of the doctrine of equivalents. Below, we break down the major legal takeaways from this case.

    1. The Reverse Doctrine of Equivalents is Questioned but Not Eliminated

    One of the most significant aspects of the ruling was the court’s discussion of RDOE, an uncommon defense to literal infringement. Shibuya argued that even if its product fell within the literal scope of Steuben’s patent claims, it operated under a different principle and should not be found infringing.

    Steuben countered that RDOE was effectively eliminated by the 1952 Patent Act, which codified infringement rules in 35 U.S.C. § 271(a) and included limitations on overly broad claims under § 112. The Federal Circuit acknowledged that RDOE has been rarely applied and that there is an argument that it may no longer be viable. However, rather than making a definitive ruling on whether RDOE survived the 1952 Patent Act, the court found that the jury had substantial evidence to reject Shibuya’s RDOE argument. As a result, the court reversed the district court’s judgment as a matter of law (JMOL) and reinstated the jury’s infringement verdict for the ‘591 patent.

    2. Means-Plus-Function Claims and the Equivalence Test

    Another key issue involved the construction of means-plus-function claims in the ‘188 patent. The claims at issue used functional language to describe components of the aseptic filling system, such as a “means for filling” bottles at a specified rate. Under § 112, ¶ 6, such claims must be construed to cover the specific structures disclosed in the patent and their equivalents.

    The district court had found that Shibuya’s accused products, which used rotary wheels and neck grippers, did not infringe the means-plus-function claims because they operated differently from the patented conveyor and conveyor plate. However, the Federal Circuit reversed, emphasizing that the equivalence test must consider whether the accused structure performs the same function in substantially the same way to achieve the same result. The court found that Steuben presented substantial evidence that Shibuya’s rotary wheels and neck grippers were equivalent to the claimed structures, leading to a reinstatement of the jury’s verdict on the ‘188 patent.

    3. Limits on the Doctrine of Equivalents

    The court upheld JMOL of noninfringement for claims in the ‘985 patent, highlighting an important limitation on the doctrine of equivalents. The issue in this case was whether a sterilization system that added sterilant “continuously” could be deemed equivalent to a claim that required it to be added “intermittently.”

    The parties had stipulated that “intermittently added” meant “[a]dded in a non-continuous manner.” Given this definition, the court held that allowing a “continuous” system to be considered equivalent would vitiate the claim limitation entirely. This ruling reinforces the principle that the doctrine of equivalents cannot be used to erase clear claim limitations.

    4. Reinstating the Jury’s Verdict and Addressing New Trial Issues

    In addition to reversing JMOL on certain infringement claims, the Federal Circuit also vacated the district court’s conditional grant of a new trial on infringement and damages. Because the district court’s reasoning for ordering a new trial was tied to its JMOL findings—many of which were overturned—the Federal Circuit found no independent basis for a new trial.

    However, the court vacated and remanded the district court’s ruling on a new trial for invalidity and damages, as the lower court had provided no clear rationale for those decisions. This signals the importance of district courts articulating their reasoning clearly when granting new trials, especially in complex patent litigation.

    Key Takeaways for Patent Holders and Defendants

    This decision offers several key lessons for patent holders and defendants in intellectual property disputes:

    1. RDOE Remains a Questionable Defense – While the court did not rule on whether RDOE survived the 1952 Patent Act, it reinforced the principle that substantial evidence from a jury trial should not be overturned lightly.
    2. Means-Plus-Function Claims Require Proper Equivalence Analysis – When dealing with § 112, ¶ 6 claims, courts must carefully compare the structure and function of the accused product to the patent’s disclosed embodiments.
    3. Doctrine of Equivalents Has Limits – The decision confirms that the doctrine of equivalents cannot be used to override explicit claim limitations, particularly when the alleged equivalent is the opposite of the claim language.
    4. District Courts Must Provide Clear Justifications for New Trials – The Federal Circuit vacated a new trial ruling because the district court failed to articulate an independent basis for it.

    Conclusion

    The Steuben Foods decision provides important guidance on several areas of intellectual property law, particularly for companies engaged in patent disputes over manufacturing processes. While the Federal Circuit did not eliminate RDOE outright, it cast doubt on its viability, reinforcing that patentees should focus on claim construction and infringement theories rather than relying on outdated doctrines. The ruling also strengthens the application of means-plus-function claims and the doctrine of equivalents while ensuring that district courts justify their decisions with clear reasoning.

    As patent litigation continues to evolve, this case serves as a reminder of the complexities of IP law and the need for strategic approaches in patent enforcement and defense.

    By Charles Gideon Korrell

  • Lynk Labs v. Samsung: Federal Circuit Clarifies Prior Art Status of Published Patent Applications in IPRs

    On January 14, 2025, the United States Court of Appeals for the Federal Circuit issued a pivotal decision in Lynk Labs, Inc. v. Samsung Electronics Co., Ltd., affirming the invalidation of certain claims in Lynk Labs’ U.S. Patent No. 10,687,400 (the ’400 patent) through inter partes review (IPR). The case primarily addressed a critical question in patent law: when does a published patent application qualify as prior art in an IPR? The Federal Circuit confirmed that a published patent application can be deemed prior art as of its filing date, significantly impacting how prior art is evaluated in IPR proceedings.

    Background of the Case

    The ’400 patent, held by Lynk Labs, pertains to alternating current (AC) driven LED technology. Samsung challenged the validity of claims 7–13 and 15–17 of the patent under 35 U.S.C. § 103 (obviousness), relying in part on U.S. Patent Application Publication No. 2004/0206970 (referred to as “Martin”). While the Martin application was filed before the priority date of the ’400 patent (February 25, 2004), it was not published until October 21, 2004. Lynk Labs contended that because Martin was not publicly available before the priority date, it should not be considered prior art in the IPR proceeding.

    Key Legal Issue: Prior Art Status of Published Patent Applications

    Lynk Labs argued that under the traditional understanding of prior art printed publications under 35 U.S.C. § 102(a) and (b), a reference must be publicly accessible before the relevant priority date to be considered prior art. In contrast, Samsung maintained that under § 102(e)(1), a U.S.-filed patent application published under 35 U.S.C. § 122(b) can be treated as prior art as of its filing date, regardless of when it became publicly accessible.

    The Federal Circuit sided with Samsung, holding that under § 102(e)(1), a published patent application serves as prior art as of its filing date, provided it was filed before the claimed invention. This interpretation aligns with prior cases recognizing that patents granted on such applications are also considered prior art as of their filing date under § 102(e)(2). The ruling underscores that Congress intended a different treatment for published patent applications compared to other printed publications such as journal articles and technical papers.

    Implications for Intellectual Property Law

    The Federal Circuit’s decision has significant implications for patent owners and IPR petitioners:

    1. Expanded Scope of Prior Art in IPRs: This ruling solidifies that a published patent application can be used as prior art in an IPR based on its filing date, even if it was not publicly available before the challenged patent’s priority date. This expands the range of prior art that can be leveraged in patent challenges.
    2. Greater Risk for Patent Holders: Patent applicants must be aware that even unpublished applications filed before their invention can be cited against them in an IPR, potentially increasing the risk of invalidation.
    3. Strategic Considerations for Patent Drafting: Innovators should carefully evaluate their filing strategies, including provisional applications and continuation practices, to ensure that their own filings are structured to avoid unintended prior art issues.

    Other Legal Issues Addressed

    Beyond the prior art issue, the court also reviewed claim construction disputes:

    • Series Connection of LEDs: The court upheld the Board’s broad interpretation of “a plurality of LEDs connected in series” to include both individual LEDs and LED circuits. This reinforced the principle that claim terms should be interpreted based on intrinsic evidence from the specification.
    • Matching Forward Voltage to Rectified Input AC Voltage: The court also agreed with the Board’s interpretation that “matches” does not require an exact equivalence but can include cases where the input voltage is less than or equal to the LED circuit’s forward voltage.

    Conclusion

    The Federal Circuit’s ruling in Lynk Labs v. Samsung provides crucial clarity on how published patent applications function as prior art in IPRs. By affirming that such applications can serve as prior art as of their filing date, the decision strengthens the ability of IPR petitioners to challenge patents using prior-filed but later-published applications. For patent holders, this ruling serves as a reminder to carefully consider prior filings when assessing patentability and preparing for potential IPR challenges. As the landscape of patent litigation continues to evolve, this case stands as a key precedent in the interpretation of prior art rules under U.S. patent law.

    By Charles Gideon Korrell

  • BEARBOX LLC v. LANCIUM LLC: A Legal Examination of Inventorship and State Law Preemption in Patent Law

    In the recent case of BearBox LLC v. Lancium LLC, the United States Court of Appeals for the Federal Circuit addressed pivotal issues concerning inventorship claims and the preemption of state law by federal patent statutes. This case underscores the intricate balance between state and federal jurisdictions in intellectual property disputes.

    Case Background

    Austin Storms, founder of BearBox LLC, engaged in discussions with Lancium LLC’s co-founders, Michael T. McNamara and Dr. Raymond E. Cline, Jr., during a Bitcoin mining conference. Subsequently, Storms sent an email containing technical information about BearBox’s technology. Lancium later secured U.S. Patent No. 10,608,433 (“the ‘433 patent”), leading Storms to assert that he should be recognized as an inventor. BearBox pursued legal action, alleging conversion under Louisiana state law and seeking correction of inventorship on the ‘433 patent.

    Key Legal Issues Addressed

    1. Preemption of State Law Conversion Claim
      • BearBox’s conversion claim centered on Lancium’s alleged unauthorized use of its unpatented technology. The district court dismissed this claim, determining it was preempted by federal patent law. The court reasoned that allowing such a state law claim would conflict with the objectives of federal patent statutes, which aim to promote public disclosure and free use of unpatented ideas. The Federal Circuit affirmed this decision, emphasizing that state laws cannot offer patent-like protection to intellectual creations unprotected under federal law.
    2. Exclusion of Supplemental Expert Report
      • BearBox submitted a supplemental expert report after the close of discovery without seeking the court’s permission. The district court excluded this report, citing procedural rules and the untimely nature of its submission. The Federal Circuit upheld this exclusion, noting that BearBox had ample opportunity to address claim construction issues earlier in the proceedings and failed to justify the delayed submission.
    3. Inventorship Claims
      • At the heart of the dispute was whether Storms should be recognized as a sole or joint inventor of the ‘433 patent. The district court, after a thorough bench trial, found that BearBox did not provide clear and convincing evidence to support Storms’ inventorship claims. The court highlighted that the information shared by Storms did not establish his conception of the claimed invention, nor did it precede Lancium’s independent development. The Federal Circuit affirmed this finding, underscoring the necessity for corroborated evidence in inventorship disputes.

    Implications for Intellectual Property Law

    This case reinforces the principle that federal patent law preempts state laws that attempt to grant patent-like protections to unpatented ideas. It also highlights the critical importance of timely and procedurally correct submissions in litigation, especially concerning expert reports. For inventors and companies, the decision underscores the necessity of maintaining thorough documentation and clear communication when collaborating or sharing technical information, as these records are vital in establishing claims of inventorship.

    In conclusion, the BearBox LLC v. Lancium LLC decision provides valuable insights into the complexities of patent law, particularly regarding the boundaries of state and federal jurisdictions and the stringent requirements for proving inventorship.

    By Charles Gideon Korrell

  • Federal Circuit Reverses Invalidity Finding for Novartis’ Entresto Patent

    On January 10, 2025, the Federal Circuit issued a significant decision in In re Entresto (Sacubitril/Valsartan) Patent Litigation, reversing a district court ruling that had found claims of Novartis’ U.S. Patent 8,101,659 (“the ’659 patent”) invalid for lack of written description. The appellate court affirmed the district court’s rulings that the patent was not invalid for obviousness or lack of enablement, solidifying Novartis’ ability to protect its blockbuster drug, Entresto®.

    This decision highlights several key patent law principles, particularly in the areas of written description, enablement, and obviousness. Here’s a breakdown of the major issues addressed by the court.

    1. Written Description – The Core Issue on Appeal

    The Federal Circuit reversed the district court’s finding that the ’659 patent lacked an adequate written description. The lower court had ruled that because the patent did not describe a valsartan-sacubitril complex, it failed the written description requirement. However, the Federal Circuit clarified that the claims did not specifically require such a complex—they covered valsartan and sacubitril administered in combination, not in a bound form.

    Key Takeaway:

    A patent’s written description must support what is actually claimed, not an unclaimed feature of the accused product. The court found that the patent sufficiently described the claimed combination therapy, even though it did not describe the later-developed valsartan-sacubitril complex.

    2. Enablement – The Patent Need Only Enable the Claimed Invention

    The district court had found that the ’659 patent enabled the claimed invention, and the Federal Circuit affirmed this conclusion. The court held that because valsartan-sacubitril complexes were unknown at the time of filing, Novartis was not required to enable them in its patent.

    Key Takeaway:

    Later-developed technologies cannot be used to argue that an earlier patent lacks enablement. If the claimed invention was enabled based on the state of the art at the time of filing, the patent remains valid.

    3. Obviousness – No Clear Motivation to Combine

    The court also upheld the district court’s ruling that the asserted claims were not obvious. The defendants (generic pharmaceutical manufacturers) argued that a person of ordinary skill in the art would have been motivated to combine an ARB (valsartan) and an NEP inhibitor (sacubitril) based on prior studies of similar drug combinations.

    However, the court found:

    • The prior art did not directly suggest combining valsartan with sacubitril.
    • Sacubitril was one of over 100 known NEP inhibitors in 2002, and it had never been tested in humans or animals for hypertension or heart failure.
    • The available studies on other NEP inhibitors showed discouraging results.

    Key Takeaway:

    Obviousness cannot be based on hindsight—just because an invention later proves effective does not mean it was obvious at the time of the patent filing.

    Conclusion: A Win for Novartis and Strong Patent Protection

    This decision strengthens Novartis’ patent protection for Entresto®, a drug with annual U.S. sales exceeding $3 billion. It reinforces the principle that:

    1. The written description requirement applies to what is actually claimed, not later-developed variants of the product.
    2. Enablement is judged based on what was known at the time of filing, not what was developed later.
    3. Obviousness must be based on clear motivation and reasonable expectation of success from the prior art.

    For pharmaceutical innovators, this case underscores the importance of careful patent drafting and robust litigation strategies. Meanwhile, for generic manufacturers, it highlights the challenges of proving invalidity when prior art does not clearly suggest the patented invention.

    By Charles Gideon Korrell

  • Functionality and Trademark Law: The Federal Circuit’s Decision in CeramTec GmbH v. CoorsTek Bioceramics LLC

    In a significant ruling on the intersection of patent and trademark law, the U.S. Court of Appeals for the Federal Circuit recently upheld the cancellation of CeramTec GmbH’s trademarks for the pink color of ceramic hip components. The court affirmed the decision of the Trademark Trial and Appeal Board (TTAB), finding that the color pink was functional and therefore ineligible for trademark protection. This decision reinforces long-standing principles regarding the limits of trademark rights when applied to functional product features.

    Background of the Case

    CeramTec, a manufacturer of ceramic hip implants, had obtained trademarks for the pink color of its zirconia-toughened alumina (ZTA) ceramic hip components, marketed as Biolox Delta. The pink coloration resulted from the addition of chromium oxide (chromia) to the ceramic, a practice that CeramTec had also covered in prior patents. However, once its patent on the composition expired, CeramTec sought to use trademark law to prevent competitors from producing similarly colored ceramic implants.

    CoorsTek, a competitor in the medical implant market, challenged these trademarks, arguing that the pink coloration was functional and not protectable under trademark law. The TTAB agreed, ruling that the pink color was functional and canceling CeramTec’s marks. CeramTec appealed this decision to the Federal Circuit.

    Key Legal Issues Addressed

    The Federal Circuit’s opinion primarily addressed two major intellectual property law issues: trademark functionality and the interaction between patents and trademarks in determining the protectability of product features.

    1. The Functionality Doctrine in Trademark Law

    The court emphasized the functionality doctrine, which prevents a manufacturer from using trademark law to claim exclusive rights over functional features of a product. The doctrine is based on the idea that trademark law should not inhibit competition by allowing a company to monopolize useful product features.

    The court applied the four-factor test established in In re Morton-Norwich Products, Inc. to determine functionality:

    • Existence of a Utility Patent: CeramTec’s expired patent explicitly disclosed that the addition of chromia provided material benefits, including increased hardness and durability.
    • Advertising that Promotes a Functional Advantage: CeramTec’s promotional and technical materials, as well as regulatory filings, repeatedly stated that chromia improved the physical properties of its ceramics.
    • Availability of Alternative Designs: The court found no compelling evidence that other ceramic hip implant colors would work equally well.
    • Impact on Manufacturing Cost and Simplicity: Conflicting evidence on whether chromia made manufacturing cheaper led the court to treat this factor as neutral.

    Given the strong evidence under the first two factors, the court concluded that the pink coloration was functional and not eligible for trademark protection.

    2. The Role of Patents in Trademark Functionality Analysis

    One of the most critical aspects of this decision was the role of CeramTec’s expired patent in proving functionality. Under the Supreme Court’s ruling in TrafFix Devices, Inc. v. Marketing Displays, Inc., a utility patent that claims a particular product feature is strong evidence that the feature is functional and cannot be protected as a trademark.

    The court dismissed CeramTec’s argument that the TrafFix standard did not apply because the patent did not explicitly claim the color pink. The Federal Circuit held that because CeramTec’s patent claimed the addition of chromia—directly responsible for the pink coloration—it was clear that the pink color was a byproduct of a functional process. The ruling reinforces that patent disclosures about functional advantages can be fatal to later trademark claims on those same features.

    Unclean Hands and Equitable Defenses

    CeramTec also attempted to raise an unclean hands defense, arguing that CoorsTek had previously asserted that chromia provided no functional benefits and should be barred from now arguing the opposite. The court rejected this defense, emphasizing that public interest in eliminating functional marks outweighed any concerns about inconsistencies in CoorsTek’s prior statements.

    Implications for Trademark and Patent Holders

    This decision serves as a stark reminder that companies cannot use trademark law to extend monopoly rights over expired patents. Once a patent expires, competitors are free to use the disclosed innovation, and trademark law cannot be used as a backdoor method of restricting competition.

    Key Takeaways for IP Practitioners:

    1. Be Cautious with Trademarking Functional Features
      If a product feature serves a functional purpose, securing a trademark may not be a viable long-term strategy for exclusivity.
    2. Prior Patents Can Undermine Trademark Claims
      A company’s own patents can serve as strong evidence that a feature is functional, making it difficult to later argue for trademark protection.
    3. Marketing and Regulatory Filings Matter
      Statements in advertising, promotional materials, and regulatory filings that tout a feature’s functional benefits can be used as evidence against trademark validity.
    4. The Functionality Doctrine Is a Strong Barrier to Color Trademarks
      While colors can sometimes be trademarked (as in Qualitex Co. v. Jacobson), courts will closely scrutinize whether the color serves a functional purpose before granting protection.

    Conclusion

    The Federal Circuit’s decision in CeramTec GmbH v. CoorsTek Bioceramics LLC reinforces core principles of trademark law by preventing the use of trademarks to monopolize functional product features. By reaffirming that expired patents serve as strong evidence of functionality, the ruling ensures that competitors can lawfully use previously patented innovations once patent protection ends. This case serves as a valuable lesson for companies looking to balance patent and trademark strategies in protecting their intellectual property.

    By Charles Gideon Korrell

  • Federal Circuit Overturns PTAB Decision in Honeywell v. 3G Licensing: A Victory for Obviousness Challenges

    On January 2, 2025, the Federal Circuit issued a significant ruling in Honeywell International Inc. v. 3G Licensing, S.A., reversing the Patent Trial and Appeal Board’s (PTAB) decision that upheld the validity of U.S. Patent No. 7,319,718. This ruling underscores the court’s approach to obviousness under 35 U.S.C. § 103 and highlights critical considerations in intellectual property disputes, particularly in standard-essential patents.

    Background: The ‘718 Patent and the CQI Coding Method

    The case centered around the ‘718 patent, which covers a method for encoding Channel Quality Indicator (CQI) data in third-generation (3G) mobile communication systems. CQI is used by mobile devices to inform base stations about network conditions, helping optimize data transmission rates.

    Honeywell and other appellants challenged the ‘718 patent in an inter partes review (IPR), arguing that the claimed method was obvious in light of prior art, particularly a proposal from Koninklijke Philips N.V. (the Philips reference). The PTAB, however, found that Honeywell failed to demonstrate a motivation to modify the Philips reference in the specific way claimed by the ‘718 patent.

    The Federal Circuit’s Analysis: Legal Issues in Patent Obviousness

    The Federal Circuit reversed the PTAB, concluding that its findings were legally flawed and unsupported by substantial evidence. The ruling focused on four major issues of patent law:

    1. Motivation to Modify Prior Art: Must It Match the Patentee’s Objective?

    The PTAB had determined that because the ‘718 patent aimed to maximize system throughput, there was no motivation for a skilled artisan to modify the Philips reference to enhance protection for the most significant bit (MSB). The Federal Circuit rejected this reasoning, reaffirming that obviousness does not require the motivation to match the patentee’s goal. Citing KSR International Co. v. Teleflex Inc., the court emphasized that any recognized need in the field—not just the inventor’s specific motivation—can support a finding of obviousness.

    2. Prior Art and the Role of Technical Modifications

    The court found that the Philips reference itself taught the desirability of protecting the MSB and that swapping two bits in the encoding table (as the ‘718 patent claimed) was a straightforward optimization. Because the modification merely involved a minor technical adjustment, it fell within the realm of routine experimentation and optimization rather than a novel innovation.

    3. Conflation of Obviousness and Anticipation

    The Federal Circuit criticized the PTAB for improperly treating the lack of an explicit proposal to swap the bits in the Philips reference as evidence of non-obviousness. The court clarified that while anticipation requires every element to be disclosed in a single prior art reference, obviousness merely requires that the claimed modification would have been a natural and logical step for a skilled person.

    4. The “Best Approach” Fallacy in Standards Development

    The PTAB had focused on the lack of consensus within the 3G standards-setting process regarding optimal CQI encoding methods. The Federal Circuit held that obviousness does not require a modification to be the “best” or “preferred” approach, only that it be a reasonable and predictable improvement.

    Implications for Patent Law and Standard-Essential Patents

    This decision reinforces the high bar for patentability in the face of well-documented prior art. Some key takeaways include:

    • Obviousness analysis should not be constrained by the inventor’s specific motivations but should consider broader industry knowledge.
    • Technical refinements and optimizations may not be patentable if they represent routine modifications of existing methods.
    • Standard-setting bodies’ debates do not necessarily shield patents from invalidity challenges—if an approach was reasonably suggested by prior art, it may still be deemed obvious.

    Conclusion

    The Federal Circuit’s decision in Honeywell v. 3G Licensing serves as a reminder that minor tweaks to well-known technologies, even when adopted into industry standards, may not be enough to sustain patent validity. As companies continue to litigate standard-essential patents, courts will likely scrutinize whether claimed inventions represent true innovation or merely expected refinements of prior art.

    This ruling is a win for companies challenging weak patents in high-tech industries and signals a continued shift toward a pragmatic and evidence-driven approach to patent law.

  • Federal Circuit Vacates PTAB Decision in Palo Alto Networks v. Centripetal Networks: Key Patent Law Takeaways

    On December 16, 2024, the Federal Circuit issued an opinion in Palo Alto Networks, Inc. v. Centripetal Networks, LLC, vacating and remanding a decision by the Patent Trial and Appeal Board (PTAB) in an inter partes review (IPR) proceeding. The ruling highlights critical issues in patent law, particularly regarding obviousness, motivation to combine, and the sufficiency of PTAB’s reasoning in IPR decisions.

    Background of the Case

    The dispute concerns U.S. Patent No. 10,530,903 (the ’903 patent), owned by Centripetal Networks, which covers a system for correlating network packets to improve cybersecurity by de-obfuscating packet sources. Palo Alto Networks (PAN) petitioned for IPR, arguing that the claims were obvious over a combination of three prior art references, with the key dispute centering on whether two references—Paxton and Sutton—could be combined to teach a crucial limitation in the patent.

    The PTAB ultimately ruled in favor of Centripetal, finding that PAN had not sufficiently demonstrated the claimed invention was obvious. PAN appealed, arguing that the Board failed to properly analyze the motivation to combine the references.

    Key Patent Law Issues Addressed

    1. Motivation to Combine and the “Necessary Bridge”

    One of the most important legal issues in this case was whether PAN had sufficiently established a motivation to combine the teachings of Paxton (which disclosed packet correlation techniques) and Sutton (which disclosed methods for notifying administrators of potential malicious activity).

    PAN contended that it would have been obvious to modify Paxton’s system by incorporating Sutton’s notification method to improve cybersecurity. The Board, however, concluded that there was no clear “bridge” between the two references that would support a motivation to combine.

    The Federal Circuit found that the Board failed to make a clear finding on the motivation to combine and did not adequately explain what it meant by the “necessary bridge” between Paxton and Sutton. The court emphasized that when an obviousness challenge is raised, the Board must explicitly find whether a motivation exists and provide a clear rationale. Citing In re Nuvasive, Inc., the court reiterated that a Board decision must include specific findings rather than vague assertions that a motivation was not sufficiently demonstrated.

    2. Evaluating Prior Art Combinations as a Whole

    The Federal Circuit also criticized the Board’s piecemeal analysis of the prior art. The PTAB evaluated Paxton and Sutton in isolation rather than considering them together as a combination. The court clarified that the correct test for obviousness is not whether any single reference discloses all claim limitations, but whether a skilled artisan would find it obvious to combine the teachings of multiple references.

    This aligns with the Supreme Court’s ruling in KSR Int’l Co. v. Teleflex Inc., which rejected a rigid approach to obviousness in favor of a more flexible, common-sense inquiry. By failing to consider the prior art references in combination, the PTAB misapplied the law and failed to properly analyze whether the combined references taught the disputed claim limitation.

    3. The Importance of Clear Reasoning in PTAB Decisions

    The Federal Circuit underscored that the PTAB’s reasoning must be sufficiently detailed to allow for meaningful appellate review. While the court does not reweigh evidence, it must ensure that the PTAB’s decisions are supported by substantial evidence and clearly articulated findings.

    The decision in this case reinforces prior holdings, such as in Gechter v. Davidson, which stress that PTAB opinions must be sufficiently reasoned and cannot leave key issues unresolved. The court found that the Board’s failure to explain whether PAN’s arguments about obviousness were valid required a remand.

    Conclusion and Impact on Future Cases

    The Federal Circuit’s decision in Palo Alto Networks v. Centripetal Networks serves as a reminder that PTAB decisions must be clear, specific, and legally sound when analyzing obviousness and motivation to combine. For practitioners handling IPRs, this case highlights the importance of:

    • Providing a well-reasoned explanation for why prior art references should or should not be combined.
    • Ensuring that PTAB panels properly evaluate prior art combinations as a whole rather than in isolation.
    • Holding PTAB accountable for issuing decisions that contain detailed findings and sufficient reasoning to withstand appellate scrutiny.

    As the case is remanded, PTAB will need to reconsider its findings on motivation to combine and whether the combined prior art discloses all claim elements. This ruling could influence future PTAB proceedings by emphasizing the need for thorough and well-supported decisions in IPR disputes.

    By Charles Gideon Korrell

  • Federal Circuit Upholds Narrow Construction of DDR Holdings’ E-Commerce Patent Claims

    The Federal Circuit recently handed down a decision in DDR Holdings, LLC v. Priceline.com LLC, affirming a lower court’s interpretation of key claim terms in DDR’s U.S. Patent No. 7,818,399 (“’399 patent”). The ruling highlights the importance of claim construction in patent infringement litigation and underscores how courts evaluate intrinsic and extrinsic evidence in determining the scope of patent claims.

    Background: The ’399 Patent and the Dispute

    DDR Holdings sued Priceline.com and Booking.com (collectively, “Priceline”) for patent infringement, alleging that their websites violated DDR’s patented method of generating composite web pages that integrate third-party merchant content while preserving the “look and feel” of a host website. The central dispute in the case revolved around the meaning of the claim terms “merchants” and “commerce object”—both of which were pivotal in determining whether Priceline’s accused websites fell within the scope of DDR’s patent.

    After years of litigation, including a stay for inter partes review (IPR) before the Patent Trial and Appeal Board (PTAB), the district court ruled in favor of Priceline, adopting a narrower construction of both disputed terms. DDR appealed, arguing that the lower court had improperly limited the claims.

    Key Patent Law Issues Addressed

    1. Claim Construction and Intrinsic Evidence

    The Federal Circuit reaffirmed its approach to claim construction under Phillips v. AWH Corp., holding that claim terms should be interpreted in light of their plain and ordinary meaning within the context of the patent specification and prosecution history. The court rejected DDR’s argument that the term “merchants” should encompass providers of both goods and services.

    A key factor in this decision was that while DDR’s provisional application mentioned merchants as providers of “products or services,” the final patent specification referred only to merchants as providers of “goods.” The court found that this omission of “services” was deliberate and indicative of the applicant’s intent to exclude services from the claim scope.

    2. The Role of Provisional Applications in Claim Interpretation

    DDR argued that because the provisional application defined merchants as providers of both goods and services, the final patent should be read the same way. The court rejected this argument, emphasizing that a provisional application does not override changes made in the final patent specification. The court cited MPHJ Technology v. Ricoh Americas, where a similar omission from a provisional to a final patent was deemed significant in limiting claim scope.

    3. Deference to the Patent Trial and Appeal Board (PTAB)

    During the IPR, the PTAB had construed “merchants” more broadly, finding that the term could include service providers. DDR attempted to use this as collateral estoppel against Priceline, arguing that the issue had already been decided. However, the Federal Circuit rejected this argument, noting that the PTAB applies a different claim construction standard—the “broadest reasonable interpretation”—whereas courts use the more nuanced Phillips standard. This ruling reinforces that district courts and the Federal Circuit are not bound by PTAB claim constructions in later litigation.

    4. Narrow Construction of “Commerce Object”

    The district court also limited the definition of “commerce object” to products (goods) only, rejecting DDR’s argument that the term should include services. The Federal Circuit upheld this decision, reasoning that the patent specification never mentioned commerce objects in the context of services, reinforcing the exclusion of services from the claim scope.

    Implications for Patent Holders

    The DDR Holdings ruling serves as a critical reminder for patent applicants and litigators:

    • Draft Patent Specifications Carefully – Courts will scrutinize changes from a provisional application to a final patent and may interpret omissions as intentional claim scope limitations.
    • Intrinsic Evidence Prevails – The Federal Circuit reaffirmed that claim meaning is primarily determined from the patent specification and prosecution history, with little room for broader interpretations from external sources.
    • IPR Decisions Don’t Control Litigation – Even if the PTAB construes claims broadly during an IPR, that does not prevent a district court from applying a narrower construction under the Phillips framework.

    Conclusion

    The Federal Circuit’s decision in DDR Holdings v. Priceline.com reinforces the importance of precise patent drafting and highlights the challenges patentees face when arguing for broader claim interpretations in court. By affirming the lower court’s narrow construction, the ruling underscores that omissions in a patent specification can significantly limit claim scope, even when broader language appeared in a provisional application.

    For companies involved in e-commerce and software patents, this case serves as a cautionary tale: when defining the scope of an invention, what’s left out of a patent can be just as important as what’s included.

    By Charles Gideon Korrell

  • Federal Circuit Upholds Sanctions for Frivolous Patent Lawsuit in PS Products v. Panther Trading

    The Federal Circuit has affirmed a district court’s sanctions against PS Products (PSP) and its attorney for filing a meritless design patent infringement case, reinforcing courts’ authority to penalize frivolous litigation. The case underscores the importance of proper venue selection, valid infringement claims, and adherence to litigation ethics.

    litigation. The case underscores the importance of proper venue selection, valid infringement claims, and adherence to litigation ethics.

    Case Background: Design Patent for Stun Device

    PS Products owns U.S. Design Patent No. D680,188, which covers a long-spiked electrode for a stun device. In May 2022, PSP sued Panther Trading Co. in the Eastern District of Arkansas, alleging that Panther’s product infringed the D’188 patent.

    However, from the outset, PSP’s case had serious defects:

    • The accused product and the patented design were “plainly dissimilar”, making infringement implausible.
    • PSP filed suit in the wrong venue, citing general venue rules instead of the patent-specific 28 U.S.C. § 1400.
    • Panther provided PSP with a prior art brochure showing a nearly identical design, raising validity concerns.
    • PSP ignored multiple warnings from Panther about the suit’s lack of merit.

    After receiving Panther’s Rule 11 sanctions warning, PSP voluntarily dismissed the case with prejudice—but refused to reimburse Panther’s legal fees.

    Panther then sought:

    1. Attorney fees under 35 U.S.C. § 285 (for exceptional cases).
    2. $100,000 in sanctions under the court’s inherent power (to deter future frivolous lawsuits).

    The district court ruled against PSP, awarding:

    • $43,344.88 in attorney fees and costs under § 285.
    • $25,000 in deterrence sanctions under its inherent authority.

    PSP appealed the sanctions to the Federal Circuit, but the court upheld the ruling.

    Key Patent Law Issues Addressed

    1. Can Courts Impose Sanctions Beyond Attorney Fees in Patent Cases?

    Yes. PSP argued that once a court grants attorney fees under § 285, it cannot impose additional sanctions under its inherent power.

    The Federal Circuit rejected this argument, citing prior cases where courts have:

    • Awarded both attorney fees and Rule 11 sanctions (Eon-Net v. Flagstar Bancorp).
    • Imposed expert witness fees in addition to attorney fees (Takeda v. Mylan).

    Key takeaway: Courts can impose multiple penalties—attorney fees plus additional sanctions—if a party engages in bad faith litigation.

    2. What Constitutes “Bad Faith” in Patent Litigation?

    The district court found PSP acted in bad faith, citing:

    1. Frivolous infringement claim: The designs were “plainly dissimilar”, making the lawsuit objectively unreasonable.
    2. Repeated venue violations: PSP filed 25 lawsuits in Arkansas using incorrect venue rules.
    3. Pattern of meritless filings: PSP dismissed over half of its past cases early, suggesting a litigation abuse strategy.

    The Federal Circuit upheld these findings, emphasizing that courts can infer bad faith from a history of filing meritless lawsuits.

    Key takeaway: A pattern of weak lawsuits can justify sanctions—especially when a party ignores procedural rules.

    3. Can Sanctions Be Imposed if Rule 11 Was Not Formally Triggered?

    Yes. PSP claimed that since Panther never formally filed a Rule 11 motion, sanctions should not apply.

    However, Rule 11 was unavailable because PSP dismissed the case before the 21-day safe harbor period expired. The district court instead used its inherent power to issue sanctions.

    The Federal Circuit ruled this was proper, citing Chambers v. NASCO:

    “When bad faith conduct occurs that cannot be adequately sanctioned under procedural rules, courts may rely on their inherent authority.”

    Key takeaway: Courts can issue sanctions under inherent authority when procedural rules don’t provide an adequate remedy.

    Final Ruling and Implications

    IssueFederal Circuit Decision
    Attorney fees under § 285Affirmed ($43,344.88 awarded)
    Additional sanctions ($25,000)Affirmed—courts can impose both
    Pattern of meritless lawsuitsSupports bad faith finding
    Improper venue claimStrengthened case for sanctions
    Panther’s request for appeal sanctionsDenied—appeal was weak but not “frivolous as argued”

    The Federal Circuit upheld all sanctions, reinforcing courts’ ability to penalize abusive litigation tactics.

    Key Takeaways for Patent Litigants

    1. Repeatedly filing weak lawsuits can backfire.
      • If a pattern emerges, courts can infer bad faith and issue sanctions.
    2. Attorney fees don’t preclude additional penalties.
      • Sanctions under Rule 11 or inherent authority can be stacked on top of § 285 attorney fees.
    3. Ignoring venue rules is risky.
      • Filing in improper venues repeatedly supports sanctions.
    4. Courts can impose sanctions even if Rule 11 is avoided.
      • Voluntarily dismissing a case before a Rule 11 motion is filed won’t necessarily protect against other penalties.
    5. Frivolous design patent claims won’t be tolerated.
      • If two designs are “plainly dissimilar”, infringement claims will likely fail fast.

    For companies dealing with aggressive litigation tactics, this ruling provides a roadmap for defending against and penalizing abusive lawsuits.

  • Federal Circuit Ruling on Crown Packaging v. Belvac: A Lesson in the On-Sale Bar

    On December 10, 2024, the Federal Circuit issued a significant ruling in Crown Packaging Technology, Inc. v. Belvac Production Machinery, Inc., reversing a district court’s decision on patent validity and reinforcing the strength of the on-sale bar under pre-AIA 35 U.S.C. § 102(b). This case highlights the importance of commercial offers for sale and their impact on patent rights.

    Background

    Crown Packaging Technology and CarnaudMetalbox Engineering (collectively, “Crown”) sued Belvac for allegedly infringing U.S. Patent Nos. 9,308,570, 9,968,982, and 10,751,784. These patents cover high-speed, multi-stage necking machines, which are used to shape the tops of metal beverage cans.

    Belvac, in turn, argued that the patents were invalid under the on-sale bar, contending that Crown had offered to sell a machine embodying the patented technology before the critical date—one year before the patent applications were filed.

    The district court ruled in favor of Crown, finding that the cited pre-critical date communications were not commercial offers for sale and that, even if they were, they did not constitute offers made “in this country.” On appeal, Belvac challenged this ruling.

    Key Patent Law Issues

    1. The On-Sale Bar and What Constitutes a Commercial Offer for Sale

    Under pre-AIA § 102(b), a patent is invalid if the invention was on sale in this country more than one year before the patent application was filed. The Supreme Court’s decision in Pfaff v. Wells Electronics, Inc. established that an invention is “on sale” if:

    1. It is the subject of a commercial offer for sale
    2. It is ready for patenting

    Crown did not dispute that the machine was ready for patenting before the critical date. However, it argued that its communications with third parties did not constitute a commercial offer for sale because they were merely quotations and not binding agreements.

    The Federal Circuit disagreed, holding that Crown’s letter to Complete Packaging Machinery in Colorado—which provided a description, price, and delivery terms for its CMB3400 necking machine—was an offer for sale.

    2. When a Quotation Becomes a Binding Offer

    Crown attempted to argue that its “Quotation Number Q22764” was not a formal offer but rather an invitation to negotiate. However, the court found several key elements indicating a definite and binding offer:

    • The letter included a specific price and payment terms (50% upfront, 50% before shipment).
    • It contained detailed delivery terms, specifying the shipment location and timeline.
    • It referenced Crown’s standard conditions of sale, which typically apply to formal purchase agreements.
    • Crown’s own internal order processing records treated similar letters as actual offers that led to binding contracts.

    Because this letter met the standard of a “commercial offer for sale”—one that could be accepted to create a binding contract—the court ruled that the on-sale bar applied.

    3. What It Means for an Offer to Be “In This Country”

    Crown also argued that, even if its letter constituted an offer, it was not an offer “in this country” because the seller (Crown) was based in the UK. The Federal Circuit rejected this argument, citing prior case law (In re Caveney and Hamilton Beach Brands v. Sunbeam Prods.), which established that an offer is “in this country” if it is directed to a U.S. entity at its place of business in the U.S.

    Since Crown’s letter was sent to Complete Packaging Machinery’s Colorado address, it qualified as an offer made in the U.S., regardless of where Crown was located.

    Conclusion: A Cautionary Tale for Patent Owners

    This case serves as a stark reminder that early commercial discussions can jeopardize patent rights. Companies should be cautious when providing detailed price quotes and delivery terms for products that embody their inventions before filing a patent application.

    Key takeaways for patent practitioners and businesses:

    ✔ A detailed price quotation can be an offer for sale.
    ✔ Offers sent to U.S. companies count as being “in this country,” even if sent from abroad.
    ✔ Internal company treatment of pre-sale communications matters—if similar communications have led to orders, they will likely be seen as binding offers.

    By reversing the district court’s decision and finding Crown’s patents invalid, the Federal Circuit reinforced the need for strategic patent filing and commercial restraint to avoid unintentional patent forfeiture.

    Would you like to discuss how this ruling might impact your patent strategy? Drop a comment below!

    By Charles Gideon Korrell